Vanadyl sulfate administration protects the streptozotocin-induced oxidative damage to brain tissue in rats

Molecular and Cellular Biochemistry

Volumn 286, Issue 1-2, 2006, Pages 153-159

  Yanardag, Refiye ^a   Tunali, Sevim ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Brain; Diabetes mellitus; Rat; Serum; Vanadyl sulfate

Indexed keywords

CATALASE; GLUCOSE; GLUTATHIONE; LACTATE DEHYDROGENASE; SIALIC ACID; STREPTOZOCIN; URIC ACID; VANADYL SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BRAIN DAMAGE; BRAIN TISSUE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE REGIMEN; DRUG EFFECT; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; GLUCOSE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN DETERMINATION; RAT STRAIN; STREPTOZOCIN DIABETES; URIC ACID BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; BRAIN; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; GLYCOSYLATION; HYPOGLYCEMIC AGENTS; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MALE; N-ACETYLNEURAMINIC ACID; OXIDATIVE STRESS; RATS; STREPTOZOCIN; URIC ACID; VANADIUM COMPOUNDS;

ANIMALIA;

EID: 33646260447     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9107-1     Document Type: Article

References (61)

1. Jung CH, Seog HM, Choi IW, Choi HD, Cho HY: Effects of wild ginseng (Panaxginseng C.A. Meyer) leaves on lipid peroxidation levels and antioxidant enzymeactivities in streptozotocin diabetic rats. J Ethnopharmacol 98: 245-250, 2005
2. Baynes JW: Role of oxidative stress in development of complications indiabetes. Diabetes 40: 405-412, 1991
3. Ceriello A: Oxidative stress and glycemic regulation. Metabolism 49:27-29, 2000
4. Young IS, Tate S, Lightbody JH, Mc Master D, Trimble ER: The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocindiabetic rat. Free Radic Biol Med 18: 833-840, 1995
5. Baynes JW,Thorpe SR: Role of oxidative stress in diabetic complications:a new perspective on an old paradigm. Diabetes 48: 1-9,1999
6. Bhor VM, Raghuram N, Sivakami S: Oxidative damage and altered antioxidant enzyme activities in the small intestine of streptozotocin-induced diabeticrats. Int Biochem Cell Biol 36: 89-97, 2004
7. Cusi K, Cukier S, Defronzo R, Torres M, Puchulu FM, Redondo JCP:VAnadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes.J Clin Endocrinol Metab 86: 1410-1417, 2001
8. Yanardag R, Bolkent S, Karabulut-Bulan O, Tunali S: Effects of vanadyl sulfate on kidney in experimental diabetes. Biol Trace Elem Res 95:73-85, 2003
9. Jound A, Lambert AE, Stauffacher W, Renold AE: Diabetogenic action of streptozotocin. Relationship of dose to metabolic response. J Clin Invest48: 2129-2139, 1969
10. Relander A, Raiha CE: Differences between the enzymatic and toluidinemethods of blood glucose determination. Scand J Clin Lab Invest 15: 221-224, 1963
11. Lorentz K, Weiβ T, Kraas E: Sialic acid in human serum andcerebrospinal fluid. J Clin Chem Clin Biochem 24: 189-198, 1986
12. Caraway WT: Determination of uric acid in serum by a carbonate method. AmJ Clin Pathol 25: 840-845, 1955
13. Aebi H: Catalase in vitro. Methods Enzymol 105: 121-126, 1984
14. Wroblewski F: Clinical significance of serum enzyme alterationsassociated with mycardial infarction. Am Heart J 54: 219-224, 1957
15. Beutler E: Glutathione in red Aell metabolism: a manual of biochemicalmethods. 2nd ed, Grune and Stratton, New York, 1975, p 112-114
16. Ledwozyw A, Michalak J, Stepien A, Kadziolka A: The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 155: 275-283,1986
17. Parker KM, England JD, Casto JD, Hessel R, Goldstein PE: Improved colorimetric assay for glycosylated hemoglobin. Clin Chem 27:669-672, 1981
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement withthe folin phenol reagent. J Biol Chem 193: 265-275, 1951
19. Musabayane CT, Mahlalela N, Shode FO, Ojewole JAO: Effects of Syzygium cordatum (Hochst.) [Myrtaceae] leaf extract on plasma glucose and hepatic glycogen instreptozotocin-induced rats. J Ethnopharmacol 97: 485-490, 2005
20. David MN, James M, Daniel ES: The epidemiology of cardiovascular disease type 2 diabetes mellitus: How sweet it is... or is it? Lancet 350:S14-S19, 1997
21. Luzi L: Pancreas transplantation and diabetic complications. N Engl JMed 339: 115-117, 1998
22. Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ: Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol CellBiochem 224: 45-51, 2001
23. Rajkumar L, Srinivasan N, Balasubramanian K, Govindarajulu P: Increased degradation of dermal collagen in diabetic rats. Indian J Exp Biol 29:1081-1083, 1991
24. Ravi K, Ramachandran B, Subramanian S: Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in streptozotocin-induced diabetic rats. Biol PharmBull 27: 1212-1217, 2004
25. Mohamed AK, Bierhaus A, Schiekofer S, Tritschler H, Ziegler H, Nawroth PP: The role of oxidative stress and NF (B) activation in late diabeticcomplications. Biofactors 10: 175-179, 1999
26. Donnini D, Zambito AM, Perella G, Ambesi-Impiombat O, Curcio F: Glucose may induce cell death through a free radical-mediated mechanism. BiochemBiophys Res Commun 219: 412-417, 1996
27. Arun N, Nalini N: Efficacy of turmeric on blood sugar and polyol pathwayin diabetic albino rats. Plant Food Hum Nutr 57: 41-52, 2002
28. Bolkent S, Bolkent S, Yanardag R, Tunali S: Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats. DiabetesRes Clin Pract 70: 103-109, 2005
29. Mohamed AAM, Mayra A, Thanaa MKR, Nabila Al-S, Nashami AS, Joseph EG: Association of serum sialic acid with cardiovascular metabolic risk factors in Kuwaiti children and adolescents with type 1 diabetes. Metabolism 53:638-643, 2004
30. Gavella M, Lipovac V, Car A, Vučić M, Sokolić L, Rakoš R: Serum sialic acid in subjects with impaired glucose tolerance and in newlydiagnosed type 2 diabetic patients. Acta Diabetol 40: 95-100, 2003
31. Crook MA, Tutt P, Pickup JC: Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy. Diabetes Care16: 57-60, 1993
32. Sillanaukee P, Ponnio M, Jaaskelainen IP: Occurrence of sialic acid inhealthy humans and different disorders. Eur J Clin Invest 29: 413-425, 1999
33. Sonmez H, Suer S, Gungor Z, Kokoglu E, Ispir T: Sialidase activities and sialic acid levels of the liver and serum from streptozotocin induceddiabetic rats. Diabetes Res 32: 101-106, 1997
34. Sung KC, Kim BS, Kang JH, Lee MH, Park JR,Rhee EJ, Lee WY, Kim SW, Kim H, Lee KB,Ryu SH: In normoglycemic Koreans, insulin resistance and adipocity are independently correlated with high blood pressure. Circ J 68: 898-902,2004
35. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH et al. Relationship between serum uric acid concentration and insulin resistance and metabolicsyndrome. Circ J 69: 928-933, 2005
36. Zavaroni I, Mazza S, Fantuzzi M, Dall'Aglio E, Bonora E, Delsignore R et al. Changes in insulin and lipid metabolism in males with asymptomatichyperuricaemia. J Intern Med 234: 25-30, 1993
37. Cigolini M, Targher G, Tonoli M, Manara F, Muggeo M, De Sandre G: Hyperuricaemia: Relationships to body fat distribution and other components of the insulin resistance sydrome in 38 years old healthy men and women. IntJ Obes Relat Metab Disord 19: 92-96, 1995
38. Yanardag R, Ozsoy-Sacan O, Orak H, Ozgey Y: Protective effects of glurenorm (qliquidone) treatment on the liver injury of experimentaldiabetes. Drug Chem Toxicol 28: 483-497, 2005
39. Rajasekaran S, Sivagnanam K, Subramanian S: Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol. Reports 57:90-96, 2005
40. Gonzales R, Auclair C, Voisin E, Gantero H, Dhermy D, Boivin P: Superoxide dismutase, catalase, and glutathione peroxidase in red blood cells from patients with malignant diseases. Cancer Res 4:4137-4139, 1984
41. Kakkar R, Kalra J, Mantha SV, Prasad K: Lipid peroxidation and activityof antioxidant enzymes in diabetic rats. Mol Cell Biochem 151: 113-119, 1995
42. Aldrich JE: Clinical enzymology. In clinical chemistry concepts and applications (eds.) Anderson, S.C.; Cockayne, S. New York: McGraw Hill;2003, 261-284
43. Navarro CM, Montilla, PM, Martin A, Jimenez J, Utrilla PM: Free radicalsscavenger and antihepatotoxic activity of Rosmarinus tomentosus. Planta Med 59: 312-314, 1993
44. Ozkaya YG, Agar A, Yargicoglu P, Hacioglu G, Bilmen-Sarikcioglu S, Ozen I, Aliciguzel Y: The effect of exercise on brain antioxidant status of diabetic rats. Diabetes Metab 28: 377-384, 2002
45. Kumar JSS, Menon VP: Effect of diabetes on levels of lipid peroxides and glycolipids inrat brain. Metabolism 42: 1435-1439, 1993
46. Nishikawa T, Edelstein D, Du XL: Normalizing mitochondrial superoxide produciton blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
47. Chiueh CC: Neuroprotective properties of nitric oxide. Ann. NY Acad Sci 890: 301-311,1999
48. Bromme HJ, Morke W, Peschke D, Ebelt H, Peschke D: Scavenging effect of melatonin on hydroxyl radicals generated by alloxan. J Pineal Res 29:201-208, 2000
49. Esterbauer H, Zollner H, Schaur RJ: Lipid Oxidation. C. Vigo and BA Pel Frey (eds). CRC Press: Boca Raton, FL 1990
50. Travero N, Menini S, Cosso L, Odetti E, Albano E, Pronzato MA, Marinari Um: Immunological evidence for increased oxidative stress in diabetic rats.Diabetologia 41: 265-270, 1998
51. Aragno M, Brignardello E, Tamagno DO, Boccuzzi G: Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemiain rats. J Endocrinol 155: 233-240, 1997
52. Suzuki WA, Clayton NS:AThe hippocampus and memory: a comparative andethnological perspective. Curr Opin Neurobiol 10: 768-773, 2000
53. Aksenov MY, Markesbery WR: Changes in thiol content and expression of glutamate redox system genes in the hippocampus and cerebellum inAlzheimer's disease. Neuroscience 302: 141-145, 2001
54. Conklin KA: Dietary antioxidants during canIer chemotherapy: impact on chemotherapeutic effectiveness and development of side effetcs. Nutr. Cancer37: 1-18, 2000
55. Rotruck JT, Pope AL, Ganther HE, Swanson AB: Selenium: Biochemicalroles as a component of glutathione peroxidase. Science 179: 588-590, 1973
56. Matcovis B, Varga SI, Szaluo L, Witsas H: The effect of diabetes on the activities of the peroxide metabolic enymes. Horm Metab Res 14:77-79, 1982
57. Yu BP: Cellular defense against damage from reactive oxygen species.Physiol Rev 1994, 74: 139-162, 1994
58. Asgary S, Naderi G, Sarrafzadegan N, Ghassemi N, Boshtam M, Rafie M, Arefian A: Anti-oxidant effect of flavonoids on hemoglobinglycosylation. Pharm Acta Helv 73: 223-226, 1999
59. Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni A: Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 20: 212-218,2001
60. Lapenna D, Ciofani G, Bruno C, Pirdomenico SD, Giuliani L, Giamberardino MA, Cuccurullo F: Vanadyl as a catalyst of human lipoprotein oxidation.Biochem Pharmacol 63: 375-380, 2002
61. Badmaev V, Prakash S, Majeed M: Vanadium: A review of its potential rolein the fight against diabetes. J Altern Complement Med 5: 273-291, 1999